The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
The North American protein drugs market is expected to grow from $235.9 billion in 2024 and is projected to reach $346.9 billion by the end of 2029, at a CAGR of 8.0% during the forecast period of 2024 to 2029.
The European protein drugs market is expected to grow from $115.2 billion in 2024 and is projected to reach $166.1 billion by the end of 2029, at a CAGR of 7.6% during the forecast period of 2024 to 2029.
Report Scope
The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. The market is segmented by product type/subtype, manufacturing technology and region. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions.
The report focuses on the trends and challenges that affect the market and the vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the rankings and market shares of leading companies in the protein drug market. It also has a section of company profiles that shows financials, product portfolios and recent developments.
Report Includes
79 data tables and 57 additional tables
An analysis of the global markets for protein drugs and their manufacturing technologies
Analyses of the global market trends, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the size of and revenue prospects for the global market, along with a market share analysis by type of protein drug, manufacturing technology, and region
Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
Analysis of the advances in manufacturing technologies, disease prevalence trends, new products , and the impact of biosimilars entering the market for protein drugs
An analysis of patents and significant patent grants
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of leading companies, including AbbVie Inc., Bristol Myer Squibb, Merck & Co., Novo Nordisk S/A, Sanofi, and Roche
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Current and Future Market Overview
Technology Background
Pharmacological Classification of Therapeutic Proteins
Protein Therapeutics with Enzymatic or Regulatory Activity
Protein Therapeutics with Special Targeting Activity
Protein Vaccines
Characteristics of Therapeutic Proteins
Macroeconomic Factors
Porter's Five Forces Analysis
Potential for New Entrants
Bargaining Power of Suppliers
Bargaining Power of Buyers
Threat of Substitute Products or Services
Competition in the Industry
Supply Chain Analysis
R&D
Manufacturing
Packaging
Wholesale Distributors and Repackagers
Pharmacies/Hospitals
Dispensed to Consumers
Chapter 3 Market Dynamics
Global Market Dynamics
Market Drivers
Advances in Manufacturing Technologies
Continuous Product Launches
Increasing Incidence of Cancer
Market Restraints
High Costs of Protein Drugs
Complex Regulatory Procedures
Market Challenges
Patent Expiration and Loss of Exclusivity
Protein Drugs Stability and Delivery
Market Opportunities
Increasing Number of Approvals for MAbs
Licensing and Collaboration Agreements
Chapter 4 Regulatory Landscape
Regulatory Scenario
Price Regulations
Chapter 5 Emerging Technologies
Overview
Emerging Technologies in Protein Drugs Market
Bispecific Antibodies and Multi-Specific Antibodies
Antibody-Drug Conjugates
Antibody Fusion Proteins
AI in the Protein Drug Market
Chapter 6 Market Segment Analysis
Overview
Segmentation Breakdown
Global Market for Protein Drugs, by Type
MAbs
Peptide Hormones
Vaccines
Blood Factors
Cytokines
Therapeutic Enzymes
Peptide Antibiotics
Fusion Proteins
Global Market for Protein Drugs, by Manufacturing Technology
Cell Culture
Microbial Fermentation
Natural Source
Embryonated Egg
Chemical Synthesis
Transgenics
Market Breakdown by Region
Global Market for Protein Drugs, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Industry Structure
Leading Protein Drugs, 2023
Market Share Analysis
MAbs
Peptide Hormones
Strategic Analysis
Acquisitions
Product Approvals
Agreements and Partnerships
Other Strategies
Chapter 8 Sustainability in the Protein Drug Market: ESG Perspective